Crescent Communities Announces Partial Redemption of 8.875% Senior Secured Notes Due 2021
May 03, 2018 20:37 pm UTC| Business
CHARLOTTE, N.C., May 03, 2018 -- Crescent Communities, LLC (the “Company”) and Crescent Ventures, Inc., a wholly owned subsidiary of the Company (together, the “Issuers”), today announced that the Issuers have given...
Advanced Emissions Solutions Announces Leadership Transitions and Business Alignment Changes
May 03, 2018 20:35 pm UTC| Business
HIGHLANDS RANCH, Colo., May 03, 2018 -- Advanced Emissions Solutions, Inc. (NASDAQ:ADES) (the “Company" or “ADES”) today announced strategic leadership changes as well as a planned workforce reduction to align the...
ARC Group Worldwide Announces Interim Chief Executive Officer Departure
May 03, 2018 20:35 pm UTC| Business
DELAND, Fla., May 03, 2018 -- ARC Group Worldwide, Inc. (“ARC” or the “Company”) (NASDAQ:ARCW) today announced that Drew M. Kelley, Interim Chief Executive Officer, will resign from the Company on May 10th, 2018. Alan...
Paylocity Announces Third Quarter Fiscal Year 2018 Financial Results
May 03, 2018 20:30 pm UTC| Business
ARLINGTON HEIGHTS, Ill., May 03, 2018 -- Paylocity Holding Corporation (NASDAQ:PCTY), a cloud-based provider of payroll and human capital management software solutions, announced today financial results for the third...
Adverum Biotechnologies Announces Leadership Changes
May 03, 2018 20:30 pm UTC| Business
MENLO PARK, Calif., May 03, 2018 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced that the board of...
Tetraphase Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Highlights
May 03, 2018 20:30 pm UTC| Business
WATERTOWN, Mass., May 03, 2018 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant...
Emergent BioSolutions Reports First Quarter 2018 Financial Results
May 03, 2018 20:30 pm UTC| Business
Reaffirms full year 2018 financial forecast and operational goalsProvides Q2 2018 revenue forecast of $205M-$230M GAITHERSBURG, Md., May 03, 2018 -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial...